These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1323 related items for PubMed ID: 28196450

  • 1. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW, Burke C, Hayde J, Walshe J, McDermott R, Desmond R, McHugh J, Enright H.
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors for therapy-related acute myeloid leukaemia (t-AML)--a single centre experience.
    Suvajdžić N, Cvetković Z, Dorđević V, Kraguljac-Kurtović N, Stanisavljević D, Bogdanović A, Djunić I, Colović N, Vidović A, Elezović I, Tomin D.
    Biomed Pharmacother; 2012 Jun; 66(4):285-92. PubMed ID: 22401928
    [Abstract] [Full Text] [Related]

  • 3. Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).
    Bally C, Thépot S, Quesnel B, Vey N, Dreyfus F, Fadlallah J, Turlure P, de Botton S, Dartigeas C, de Renzis B, Itzykson R, Fenaux P, Adès L.
    Leuk Res; 2013 Jun; 37(6):637-40. PubMed ID: 23499498
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS, Medeiros BC, Sengeløv H, Nørgaard M, Andersen MK, Dufva IH, Friis LS, Kjeldsen E, Marcher CW, Preiss B, Severinsen M, Nørgaard JM.
    J Clin Oncol; 2015 Nov 01; 33(31):3641-9. PubMed ID: 26304885
    [Abstract] [Full Text] [Related]

  • 5. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
    Ong DM, Farrugia H, Wei A.
    Intern Med J; 2018 Jul 01; 48(7):822-829. PubMed ID: 29236346
    [Abstract] [Full Text] [Related]

  • 6. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
    Aguilera DG, Vaklavas C, Tsimberidou AM, Wen S, Medeiros LJ, Corey SJ.
    J Pediatr Hematol Oncol; 2009 Nov 01; 31(11):803-11. PubMed ID: 19801947
    [Abstract] [Full Text] [Related]

  • 7. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
    Jonsdottir G, Björkholm M, Turesson I, Hultcrantz M, Diamond B, Porwit A, Landgren O, Kristinsson SY.
    Eur J Haematol; 2021 Aug 01; 107(2):275-282. PubMed ID: 33966293
    [Abstract] [Full Text] [Related]

  • 8. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
    Kaplan HG, Malmgren JA, Atwood MK.
    BMC Cancer; 2011 Jun 21; 11():260. PubMed ID: 21693006
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N, Albin M, Rylander L, Billström R, Ahlgren T, Mikoczy Z, Björk J, Strömberg U, Nilsson PG, Mitelman F, Hagmar L, Johansson B.
    Leukemia; 2002 Dec 21; 16(12):2366-78. PubMed ID: 12454741
    [Abstract] [Full Text] [Related]

  • 11. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
    Edlin R, Connock M, Tubeuf S, Round J, Fry-Smith A, Hyde C, Greenheld W.
    Health Technol Assess; 2010 May 21; 14 Suppl 1():69-74. PubMed ID: 20507806
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.
    Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP.
    J Clin Oncol; 2012 Jul 01; 30(19):2340-7. PubMed ID: 22585703
    [Abstract] [Full Text] [Related]

  • 15. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.
    Klimek VM.
    Curr Opin Hematol; 2013 Mar 01; 20(2):137-43. PubMed ID: 23343830
    [Abstract] [Full Text] [Related]

  • 16. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
    van der Helm LH, Alhan C, Wijermans PW, van Marwijk Kooy M, Schaafsma R, Biemond BJ, Beeker A, Hoogendoorn M, van Rees BP, de Weerdt O, Wegman J, Libourel WJ, Luykx-de Bakker SA, Minnema MC, Brouwer RE, Croon-de Boer F, Eefting M, Jie KS, van de Loosdrecht AA, Koedam J, Veeger NJ, Vellenga E, Huls G.
    Br J Haematol; 2011 Dec 01; 155(5):599-606. PubMed ID: 21981697
    [Abstract] [Full Text] [Related]

  • 17. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
    Wang R, Zeidan AM, Yu JB, Soulos PR, Davidoff AJ, Gore SD, Huntington SF, Gross CP, Ma X.
    Prostate; 2017 Apr 01; 77(5):437-445. PubMed ID: 27868212
    [Abstract] [Full Text] [Related]

  • 18. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
    Takahashi K, Wang F, Kantarjian H, Doss D, Khanna K, Thompson E, Zhao L, Patel K, Neelapu S, Gumbs C, Bueso-Ramos C, DiNardo CD, Colla S, Ravandi F, Zhang J, Huang X, Wu X, Samaniego F, Garcia-Manero G, Futreal PA.
    Lancet Oncol; 2017 Jan 01; 18(1):100-111. PubMed ID: 27923552
    [Abstract] [Full Text] [Related]

  • 19. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A, Pond GR, Mitsakakis N, Brandwein J, Chun K, Gupta V, Kamel-Reid S, Lipton JH, Minden MD, Schimmer A, Schuh A, Yee K, Messner HA.
    Cancer; 2008 Apr 01; 112(7):1513-21. PubMed ID: 18286528
    [Abstract] [Full Text] [Related]

  • 20. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X, Maciejewski J, Pollyea DA, Savona MR, Scott B, Sekeres MA, Thompson MA, Swern AS, Nifenecker M, Sugrue MM, Erba H.
    BMC Cancer; 2016 Aug 19; 16():652. PubMed ID: 27538433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.